RYTM ▼ -3.8% - Rhythm Pharmaceuticals, Inc.
$RYTM reported Q3 2026 EPS of -$0.61, beating the -$0.73 estimate by 16.4%. Revenue of $92.1M beat the $84.6M estimate by 8.9%.
03-NOV-2026 07:07 AM ET
Share this post
More filings for $RYTM
RYTM ▼ -3.8% - Rhythm Pharmaceuticals, Inc.Nov 3, 2026RYTM ▲ +1.0% - Rhythm Pharmaceuticals, Inc.Nov 3, 2026RYTM ▲ +0.3% - Rhythm Pharmaceuticals, Inc.Oct 21, 2026RYTM ▼ -2.5% - Rhythm Pharmaceuticals, Inc.Oct 13, 2026RYTM - Rhythm Pharmaceuticals, Inc. - SEC Filing Update (13-OCT-2026) | ThinkSabio - Stocks SimplifiedOct 13, 2026RYTM ▼ -0.0% - Rhythm Pharmaceuticals, Inc.Sep 22, 2026
View full $RYTM filing history →💬 Comments
Loading comments…
Leave a comment